Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Risteli

Showing results (171-180 of 294) with videos related to

Pageof 30
Sort By:
British Journal of Cancer|January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerT Kylmälä, T Taube, T L Tammela, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 18, 2004
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptideRiitta Tähtelä, J Seppänen, K Laitinen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometryE F Eriksen, P Charles, F Melsen, et al.
Journal of Hepatology|April 3, 2001
Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up studyH Isoniemi, J Appelberg, C G Nilsson, et al.
Acta Endocrinologica|November 1, 1993
Possible variation in bone resorption during the normal menstrual cycleA Schlemmer, C Hassager, J Risteli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 23, 1998
Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapyE Suvanto-Luukkonen, L Risteli, H Sundström, et al.
Calcified Tissue International|December 1, 1992
Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue levelP Charles, C Hasling, L Risteli, et al.
Cancer|February 15, 1995
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasmsG G Zhu, L Risteli, M Mäkinen, et al.
British Journal of Rheumatology|November 1, 1994
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-upL Paimela, M Leirisalo-Repo, L Risteli, et al.
European Journal of Clinical Investigation|December 1, 1993
Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagenL T Jensen, J H Henriksen, H P Olesen, et al.
Pageof 30

Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerT Kylmälä, T Taube, T L Tammela, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 18, 2004
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptideRiitta Tähtelä, J Seppänen, K Laitinen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometryE F Eriksen, P Charles, F Melsen, et al.
Journal of Hepatology|April 3, 2001
Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up studyH Isoniemi, J Appelberg, C G Nilsson, et al.
Acta Endocrinologica|November 1, 1993
Possible variation in bone resorption during the normal menstrual cycleA Schlemmer, C Hassager, J Risteli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 23, 1998
Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapyE Suvanto-Luukkonen, L Risteli, H Sundström, et al.
Calcified Tissue International|December 1, 1992
Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue levelP Charles, C Hasling, L Risteli, et al.
Cancer|February 15, 1995
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasmsG G Zhu, L Risteli, M Mäkinen, et al.
British Journal of Rheumatology|November 1, 1994
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-upL Paimela, M Leirisalo-Repo, L Risteli, et al.
European Journal of Clinical Investigation|December 1, 1993
Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagenL T Jensen, J H Henriksen, H P Olesen, et al.
Pageof 30